Tresiba® side effects
The most common side effect of Tresiba® is low blood sugar (hypoglycemia). For most people, low blood sugar is when the amount of sugar in your blood drops to 70 mg/dL or lower. You should ask your diabetes care team what level of blood sugar is too low for you. Low blood sugar is something that you need to be prepared to treat, so it's important to know the signs.
These are not all the possible symptoms of low blood sugar. See the full list of symptoms below:
A continuous glucose monitor (CGM) is a small sensor inserted under the skin that measures blood glucose. The system can display real-time glucose levels at 1- and 5-minute intervals, and alarms can be set to alert patients of high or low glucose levels. This can help manage side effects related to hypoglycemia.
For a complete list of possible side effects of Tresiba®, see the Prescribing Information and Important Safety Information below.
For medical advice about side effects, talk with your health care provider. You may report side effects to the FDA at 1-800-FDA-1088.
In a large safety study vs Lantus® in adults with type 2 diabetes and heart disease, Tresiba® did not increase their risk of major cardiovascular events, such as heart attack, stroke, or death.
Patients taking Tresiba® also had a lower rate of severe low blood sugar, a possible serious side effect of insulin, compared to Lantus®.
© 2022 Novo Nordisk All rights reserved. US22TSM00252 December 2022